PABFX
Price
$19.59
Change
-$0.20 (-1.01%)
Updated
Nov 13 closing price
Net Assets
1.06B
RLBCX
Price
$38.80
Change
-$0.48 (-1.22%)
Updated
Nov 13 closing price
Net Assets
268.67B
Interact to see
Advertisement

PABFX vs RLBCX

Header iconPABFX vs RLBCX Comparison
Open Charts PABFX vs RLBCXBanner chart's image
PGIM Balanced Z
Price$19.59
Change-$0.20 (-1.01%)
VolumeN/A
Net Assets1.06B
American Funds American Balanced R3
Price$38.80
Change-$0.48 (-1.22%)
VolumeN/A
Net Assets268.67B
PABFX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
PABFX vs. RLBCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABFX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 269B vs. PABFX (1.06B). PABFX pays higher dividends than RLBCX: PABFX (2.12) vs RLBCX (1.46). PABFX was incepted earlier than RLBCX: PABFX (33 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than PABFX (0.84). PABFX is a more actively managed with annual turnover of: 107.00 vs. RLBCX (44.00). PABFX has a lower initial minimum investment than RLBCX: PABFX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 8.39 vs. PABFX (7.70). RLBCX return over 5 years is better than : 37.74 vs. PABFX (29.09).
PABFXRLBCXPABFX / RLBCX
Total Expense Ratio0.780.8988%
Annual Report Gross Expense Ratio0.840.8994%
Fund Existence33 years23 years-
Gain YTD14.85914.512102%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B269B0%
Annual Yield % from dividends2.121.46145%
Returns for 1 year7.708.3992%
Returns for 3 years42.5141.39103%
Returns for 5 years29.0937.7477%
Returns for 10 years53.2470.8775%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COR363.42-1.66
-0.45%
Cencora
NVRI13.35-0.18
-1.33%
Enviri Corp
DOUG2.61-0.04
-1.51%
Douglas Elliman
CRSP52.19-3.02
-5.47%
CRISPR Therapeutics AG
RBOT4.12-0.45
-9.85%
Vicarious Surgical